๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Blood sample clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 58 trials in our France, Germany, Italy and Belgium registers that name Blood sample as an intervention. Synced 26 Sep 2026
58Current trials
43Recruiting now
23Lead sponsors
4Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards
At a glance

Blood sample is named as an intervention in 58 current clinical trials in our France, Germany, Italy and Belgium registers. 43 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Centre Hospitalier Universitaire, Amiens (12). The most-studied condition is Systemic Lupus Erythematosus.

Trials by status

  • Recruiting4374%
  • Not yet open1119%
  • Active, closed47%

Trials by phase

  • Not applicable3357%
  • Observational2034%
  • Phase 235%
  • Phase 323%
01

Clinical trials of Blood sample

58 trials
StudyPhaseStatusLead sponsorRegisters
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
NCT05040464 · ClinicalTrials.gov ↗ · Crohn Disease, Azathioprine, Methotrexate
Phase 3 Recruiting Centre Hospitalier Universitaire, Amiens France
The Effects of the Female Hormones on Cerebral Perfusion
NCT03299179 · ClinicalTrials.gov ↗ · Cerebral Perfusion, Contraception, Menstrual Cycle
Observational Recruiting University Ghent Belgium
Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
NCT04005638 · ClinicalTrials.gov ↗ · Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Autoimmune Neutropenia
Observational Recruiting University Hospital, Bordeaux France
SERum-bank for PANcreatic Cancer
NCT04374175 · ClinicalTrials.gov ↗ · Adenocarcinoma
Observational Recruiting Centre Hospitalier Universitaire de Saint Etienne France
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
NCT04377490 · ClinicalTrials.gov ↗ · COVID-19, Hemostasis, Coagulation
Observational Recruiting Centre Hospitalier Universitaire, Amiens France
Sarcopenia and Nutritional Status in a Rehabilitation Setting
NCT04791540 · ClinicalTrials.gov ↗ · Sarcopenia
Observational Recruiting Fondazione Don Carlo Gnocchi ETS Italy
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
NCT05288842 · ClinicalTrials.gov ↗ · Alzheimer Disease, Frontotemporal Dementia
Observational Recruiting University Hospital, Lille France
Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension
NCT05340023 · ClinicalTrials.gov ↗ · Chronic Thromboembolic Pulmonary Hypertension
Observational Recruiting Centre Hospitalier Universitaire de Saint Etienne France
Basal Plasma Lithium Levels and Suicidal Events
NCT05409794 · ClinicalTrials.gov ↗ · Major Depressive Disorder, Suicidal Behavior, Bipolar Disorder
Observational Recruiting University Hospital, Montpellier France
The Diagnostic Observatory: Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network
NCT05448326 · ClinicalTrials.gov ↗ · Developmental Abnormality
Observational Recruiting Centre Hospitalier Universitaire Dijon France
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 · ClinicalTrials.gov ↗ · Juvenile Idiopathic Arthritis (JIA)
Observational Recruiting Assistance Publique - Hรดpitaux de Paris France
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
NCT05859191 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus, Physiopathology
Observational Recruiting University Hospital, Tours France
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414 · ClinicalTrials.gov ↗ · Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease, Cystic Fibrosis
Observational Recruiting Assistance Publique - Hรดpitaux de Paris France
Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
NCT06430021 · ClinicalTrials.gov ↗ · Neuroendocrine Tumors, MEN1 Mutation
Observational Recruiting Centre Hospitalier Universitaire Dijon France
Cohort of Patients With Systemic Granulomatosis and Associated Biological Collection
NCT06854848 · ClinicalTrials.gov ↗ · Granulomatosis
Observational Recruiting University Hospital, Bordeaux France
Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study
NCT07174141 · ClinicalTrials.gov ↗ · Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)
Observational Recruiting Centre Hospitalier Universitaire Dijon France
A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital Anomalies
NCT07686653 · ClinicalTrials.gov ↗ · Genetic, Diagnostic Strategies
Observational Recruiting Centre Hospitalier Universitaire Dijon France
Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
NCT07820566 · ClinicalTrials.gov ↗ · Kidney Cancers, Bladder Cancer, Prostate Cancer
Observational Recruiting University Hospital, Strasbourg, France France
Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways
NCT02923440 · ClinicalTrials.gov ↗ · Congenital Heart Defects
Not applicable Recruiting Assistance Publique Hopitaux De Marseille France
Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03357172 · ClinicalTrials.gov ↗ · Allogeneic Hematopoietic Stem Cell Transplantation
Not applicable Recruiting Central Hospital, Nancy, France France
Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
NCT03526822 · ClinicalTrials.gov ↗ · Brain Tumor
Not applicable Recruiting Assistance Publique Hopitaux De Marseille France
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NCT04119908 · ClinicalTrials.gov ↗ · Von Willebrand Diseases, Glanzmann Thrombasthenia
Not applicable Recruiting University Hospital, Lille France
Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?
NCT04711746 · ClinicalTrials.gov ↗ · Pulmonary Embolism, Hematopoiesis
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
NCT04798651 · ClinicalTrials.gov ↗ · Multiple Sclerosis, Clinically Isolated Syndrome
Not applicable Recruiting University Hospital, Bordeaux France
Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenstrรถm Macroglobulinemia
NCT04893564 · ClinicalTrials.gov ↗ · Waldenstrom's Disease, Waldenstrom Macroglobulinemia
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Clinical Study of the Hyperviscosity Syndrome in Waldenstrรถm Macroglobulinemia
NCT04898647 · ClinicalTrials.gov ↗ · Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
NCT05267041 · ClinicalTrials.gov ↗ · Lung Cancer
Not applicable Recruiting Hospices Civils de Lyon France
Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
NCT05384392 · ClinicalTrials.gov ↗ · First-episode Psychosis
Not applicable Recruiting University Hospital, Brest France
Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage
NCT05648136 · ClinicalTrials.gov ↗ · Repeated Embryo Implantation Failure, Recurrent Miscarriage, Immune System
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Systemic Lupus Erythematosus and Accelerated Aging
NCT05698173 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus
Not applicable Recruiting University Hospital, Bordeaux France
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 · ClinicalTrials.gov ↗ · Locally Advanced Head and Neck Carcinoma
Not applicable Recruiting Centre Jean Perrin France
Engineering Immune Organoids to Study Pediatric Cancer
NCT05890781 · ClinicalTrials.gov ↗ · Brain Tumor, Kidney Tumor, Neuroblastoma
Not applicable Recruiting Gustave Roussy, Cancer Campus, Grand Paris France
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 · ClinicalTrials.gov ↗ · Asthma Acute
Not applicable Recruiting Institut National de la Santรฉ Et de la Recherche Mรฉdicale, France France
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
NCT06033183 · ClinicalTrials.gov ↗ · Radiosensitivity, Pediatric Cancer, Radiation Toxicity
Not applicable Recruiting Neolys France
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 · ClinicalTrials.gov ↗ · Heparin-induced Thrombocytopenia, HIT, Platelet Activation
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Genomic Study of Cutis Tricolor
NCT06073171 · ClinicalTrials.gov ↗ · Pigmentary; Dermatosis
Not applicable Recruiting University Hospital, Montpellier France
Improvement of Symptoms After Removal of the Essureยฎ Contraceptive Implant
NCT06355713 · ClinicalTrials.gov ↗ · Implant Complication, Contraceptive Device; Complications
Not applicable Recruiting Hospices Civils de Lyon France
Screening for Familial Hypercholesterolemia in Children
NCT06555120 · ClinicalTrials.gov ↗ · Hypercholesterolemia, Familial
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
The Study of the Phenotype of Hereditary Xerocytosis
NCT06892171 · ClinicalTrials.gov ↗ · Xerocytosis, Phenotype, Genotype
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock
NCT07203833 · ClinicalTrials.gov ↗ · Vasorin, Septic Shock, Shock
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus
NCT07260942 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus
Not applicable Recruiting University Hospital, Bordeaux France
CRP Point-of-care Testing Trajectory, a Predictive Factor for Anastomotic Leak in Elective Colorectal Surgery
NCT07464600 · ClinicalTrials.gov ↗ · Colorectal Surgery, Enhanced Recovery, CRP Point-of-care Testing Trajectory
Not applicable Recruiting Centre Hospitalier Universitaire, Amiens France
Study of the Impact of Phosphate Supplementation on FGF23 Concentrations in Patients With Hypophosphatemia
NCT07827989 · ClinicalTrials.gov ↗ · Calcium-phosphorus Metabolism
Not applicable Recruiting University Hospital, Clermont-Ferrand France
Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients
NCT05241561 · ClinicalTrials.gov ↗ · Cancer of Kidney
Phase 2 Not yet open Centre Hospitalier Universitaire de Besancon France
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
NCT06356740 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus
Phase 2 Not yet open Hospices Civils de Lyon France
Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic Toxins
NCT06595680 · ClinicalTrials.gov ↗ · End Stage Renal Disease, Chronic Hemolysis
Phase 2 Not yet open Hospices Civils de Lyon France
Translational Potential of ex Vivo Gene Therapy in GM2 Gangliosidosis
NCT07445490 · ClinicalTrials.gov ↗ · Tay-Sachs Disease Ganglioside, Sandhoff Disease Ganglioside
Observational Not yet open Assistance Publique - Hรดpitaux de Paris France
Study of the Hypothalamic Microglial Response as a Function of a Meal's Lipid Content in Humans. A Single-center Prospective Cohort Study in Healthy Male Subjects
NCT07557628 · ClinicalTrials.gov ↗ · Pathophysiology
Observational Not yet open Centre Hospitalier Universitaire Dijon France
The Potential of Mesenchymal Stromal Stem Cells to Correct Immune and Metabolic Dysfunctions in Circulating Immune Cells During Sepsis: An Ex Vivo Pilot Study.
NCT07812012 · ClinicalTrials.gov ↗ · Sepsis
Observational Not yet open Centre Hospitalier Universitaire Dijon France
Multiparametric MRI Assessment of Atrial Heart Disease as a Predictor of Atrial Fibrillation After Myocardial Revascularization Surgery
NCT04657835 · ClinicalTrials.gov ↗ · Postoperative Atrial Fibrillation
Not applicable Not yet open Centre Hospitalier Universitaire de Saint Etienne France
Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)
NCT06711770 · ClinicalTrials.gov ↗ · Non Small Cell Lung Cancer, Immunotherapy, Granulocyte Colony Stimulating Factor
Not applicable Not yet open University Hospital, Bordeaux France
Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation
NCT06887075 · ClinicalTrials.gov ↗ · Chronic Kidney Failure, Frailty, Aging
Not applicable Not yet open University Hospital, Bordeaux France
Homeostatic Regulation of Sleep in Short Sleepers
NCT07584538 · ClinicalTrials.gov ↗ · Short Sleepers, Normal Sleepers, Idiopathic Hypersomnia Patients
Not applicable Not yet open University Hospital, Montpellier France
Study of the Effects of Acute Exposure to Moderate Altitude Hypoxia on Prospective Memory.
NCT07585227 · ClinicalTrials.gov ↗ · Hypoxia, Hypoxia Brain, Hypoxia Altitude Simulation Test
Not applicable Not yet open Direction Centrale du Service de Santรฉ des Armรฉes France
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol
NCT05458622 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus (SLE)
Phase 3 Active, closed University Hospital, Brest France
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)
NCT03252717 · ClinicalTrials.gov ↗ · Breast Cancer
Not applicable Active, closed Institut du Cancer de Montpellier - Val d'Aurelle France
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus
Not applicable Active, closed University Hospital, Bordeaux Germany, France
COVID-19 Serology and Immunosenescence
NCT04563650 · ClinicalTrials.gov ↗ · Covid19, Geriatric Medicine, Seroconversion
Not applicable Active, closed Centre Hospitalier Universitaire, Amiens France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Blood sample

110 conditions
Systemic Lupus Erythematosus5Brain Tumor2Waldenstrom Macroglobulinemia2Pigmentary; Dermatosis1Juvenile Idiopathic Arthritis (JIA)1Lung Cancer1Multiple Sclerosis1Clinically Isolated Syndrome1Colorectal Surgery1Enhanced Recovery1CRP Point-of-care Testing Trajectory1Post-operative Complication1
All 110 conditions
Condition (as registered)Trials
Systemic Lupus Erythematosus5
Brain Tumor2
Waldenstrom Macroglobulinemia2
Pigmentary; Dermatosis1
Juvenile Idiopathic Arthritis (JIA)1
Lung Cancer1
Multiple Sclerosis1
Clinically Isolated Syndrome1
Colorectal Surgery1
Enhanced Recovery1
CRP Point-of-care Testing Trajectory1
Post-operative Complication1
Crohn Disease1
Azathioprine1
Methotrexate1
Allogeneic Hematopoietic Stem Cell Transplantation1
Von Willebrand Diseases1
Glanzmann Thrombasthenia1
Kidney Cancers1
Bladder Cancer1
Prostate Cancer1
Alzheimer Disease1
Frontotemporal Dementia1
Implant Complication1
Contraceptive Device; Complications1
End Stage Renal Disease1
Chronic Hemolysis1
Congenital Heart Defects1
Vasorin1
Septic Shock1
Shock1
Biomarker1
Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)1
Neuroendocrine Tumors1
MEN1 Mutation1
Short Sleepers1
Normal Sleepers1
Idiopathic Hypersomnia Patients1
Asthma Acute1
Postoperative Atrial Fibrillation1
Physiopathology1
Genetic1
Diagnostic Strategies1
Chronic Kidney Failure1
Frailty1
Aging1
Inflammation1
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including1
Sickle Cell Disease1
Cystic Fibrosis1
Fragile X Syndrome1
Locally Advanced Head and Neck Carcinoma1
Waldenstrom's Disease1
Developmental Abnormality1
Hypercholesterolemia, Familial1
Hypoxia1
Hypoxia Brain1
Hypoxia Altitude Simulation Test1
Hypoxia in Healthy Individuals1
Pulmonary Embolism1
Hematopoiesis1
Sepsis1
First-episode Psychosis1
Chronic Thromboembolic Pulmonary Hypertension1
Calcium-phosphorus Metabolism1
Pathophysiology1
Repeated Embryo Implantation Failure1
Recurrent Miscarriage1
Immune System1
COVID-191
Hemostasis1
Coagulation1
Systemic Lupus Erythematosus (SLE)1
Cancer of Kidney1
Adenocarcinoma1
Kidney Tumor1
Neuroblastoma1
Sarcoma1
Heparin-induced Thrombocytopenia1
HIT1
Platelet Activation1
Platelets1
Tay-Sachs Disease Ganglioside1
Sandhoff Disease Ganglioside1
Breast Cancer1
Immune Thrombocytopenia1
Autoimmune Hemolytic Anemia1
Autoimmune Neutropenia1
Major Depressive Disorder1
Suicidal Behavior1
Bipolar Disorder1
Hyperviscosity Syndrome1
Radiosensitivity1
Pediatric Cancer1
Radiation Toxicity1
Non Small Cell Lung Cancer1
Immunotherapy1
Granulocyte Colony Stimulating Factor1
Granulomatosis1
Covid191
Geriatric Medicine1
Seroconversion1
Immunosenescence1
Xerocytosis1
Phenotype1
Genotype1
Sarcopenia1
Cerebral Perfusion1
Contraception1
Menstrual Cycle1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Centre Hospitalier Universitaire, Amiens12
University Hospital, Bordeaux8
Centre Hospitalier Universitaire Dijon6
Hospices Civils de Lyon4
University Hospital, Montpellier3
Assistance Publique - Hรดpitaux de Paris3
Centre Hospitalier Universitaire de Saint Etienne3
Assistance Publique Hopitaux De Marseille2
University Hospital, Lille2
University Hospital, Brest2
Central Hospital, Nancy, France1
University Hospital, Strasbourg, France1
Institut National de la Santรฉ Et de la Recherche Mรฉdicale, France1
University Hospital, Tours1
Centre Jean Perrin1

+ 8 more sponsors in the trial list above.

04

By country register

RegisterTrialsRecruiting
Clinical trials in France5641
Clinical trials in Germany10
Clinical trials in Italy11
Clinical trials in Belgium11

A trial with sites in more than one country appears in each of those registers.

05

Related compounds

06

Questions about Blood sample trials

How many clinical trials are testing Blood sample?

58 current trials in our France, Germany, Italy and Belgium registers name Blood sample as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Blood sample trials recruiting patients?

Yes. 43 of the 58 trials are recruiting: 41 with sites in France, 1 with sites in Italy and 1 with sites in Belgium. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Blood sample clinical trials?

Centre Hospitalier Universitaire, Amiens (12), University Hospital, Bordeaux (8), Centre Hospitalier Universitaire Dijon (6) and Hospices Civils de Lyon (4), among 23 lead sponsors in total. The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Blood sample works or whether it is effective, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Blood sample works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Blood sample (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.